Barrington Research Cuts U.S. Physical Therapy (NYSE:USPH) Price Target to $90.00

Posted by Francis Steltz on May 13th, 2026

U.S. Physical Therapy (NYSE:USPH – Get Free Report) had its price target lowered by analysts at Barrington Research from $103.00 to $90.00 in a research report issued on Wednesday. The brokerage presently has an “outperform” rating on the stock. Barrington Research’s target price would suggest a potential upside of 47.42% from the stock’s previous close.

A number of other equities analysts have also weighed in on the stock. Jefferies Financial Group raised shares of U.S. Physical Therapy to a “strong-buy” rating in a research report on Thursday, March 12th. Zacks Research cut shares of U.S. Physical Therapy from a “hold” rating to a “strong sell” rating in a research note on Tuesday, April 28th. Citizens Jmp cut their price target on U.S. Physical Therapy from $113.00 to $98.00 and set a “market outperform” rating for the company in a report on Friday, May 8th. Weiss Ratings reissued a “hold (c)” rating on shares of U.S. Physical Therapy in a research note on Wednesday, January 21st. Finally, Citigroup restated an “outperform” rating on shares of U.S. Physical Therapy in a report on Friday. One equities research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $97.50.

Read Our Latest Stock Report on USPH

U.S. Physical Therapy Stock Up 2.7%

USPH opened at $61.05 on Wednesday. The firm has a market cap of $929.15 million, a P/E ratio of 122.10, a PEG ratio of 1.73 and a beta of 1.21. The business’s fifty day simple moving average is $74.93 and its 200 day simple moving average is $78.90. U.S. Physical Therapy has a 52 week low of $58.19 and a 52 week high of $93.50. The company has a quick ratio of 1.01, a current ratio of 1.19 and a debt-to-equity ratio of 0.41.

U.S. Physical Therapy (NYSE:USPH – Get Free Report) last announced its earnings results on Wednesday, May 6th. The company reported $0.46 earnings per share for the quarter, missing the consensus estimate of $0.55 by ($0.09). U.S. Physical Therapy had a net margin of 4.36% and a return on equity of 8.81%. The firm had revenue of $198.29 million during the quarter, compared to analyst estimates of $200.94 million. During the same period in the previous year, the firm posted $0.48 EPS. The company’s revenue for the quarter was up 7.9% compared to the same quarter last year. As a group, equities research analysts anticipate that U.S. Physical Therapy will post 2.83 EPS for the current fiscal year.

Insider Buying and Selling

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 662 shares of the business’s stock in a transaction that occurred on Wednesday, March 11th. The shares were sold at an average price of $78.86, for a total transaction of $52,205.32. Following the completion of the sale, the chief operating officer directly owned 30,078 shares in the company, valued at $2,371,951.08. The trade was a 2.15% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Richard Binstein sold 3,000 shares of the stock in a transaction on Friday, March 6th. The stock was sold at an average price of $81.64, for a total transaction of $244,920.00. Following the completion of the sale, the executive vice president directly owned 24,867 shares of the company’s stock, valued at $2,030,141.88. The trade was a 10.77% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders own 2.00% of the company’s stock.

Institutional Trading of U.S. Physical Therapy

A number of institutional investors have recently added to or reduced their stakes in the business. Vanguard Group Inc. increased its holdings in U.S. Physical Therapy by 1.5% in the 4th quarter. Vanguard Group Inc. now owns 1,085,336 shares of the company’s stock valued at $84,754,000 after purchasing an additional 15,712 shares in the last quarter. Copeland Capital Management LLC lifted its stake in shares of U.S. Physical Therapy by 6.5% during the first quarter. Copeland Capital Management LLC now owns 836,831 shares of the company’s stock worth $62,729,000 after purchasing an additional 50,717 shares in the last quarter. Dimensional Fund Advisors LP boosted its position in shares of U.S. Physical Therapy by 3.2% in the first quarter. Dimensional Fund Advisors LP now owns 507,394 shares of the company’s stock worth $38,035,000 after buying an additional 15,668 shares during the period. Bahl & Gaynor Inc. boosted its position in shares of U.S. Physical Therapy by 47.6% in the third quarter. Bahl & Gaynor Inc. now owns 474,688 shares of the company’s stock worth $40,325,000 after buying an additional 153,054 shares during the period. Finally, William Blair Investment Management LLC grew its stake in shares of U.S. Physical Therapy by 7.2% in the fourth quarter. William Blair Investment Management LLC now owns 370,707 shares of the company’s stock valued at $28,949,000 after buying an additional 24,848 shares in the last quarter.

About U.S. Physical Therapy

(Get Free Report)

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.